-
Tebideutorexant (developmental code
names JNJ-61393215, JNJ-3215) is an
orexin antagonist medication which is
under development for the
treatment of depression...
- disorder, insomnia, and
sleep apnea, up to
phase 3 – half-life 2–3
hours Tebideutorexant (JNJ-61393215, JNJ-3215) –
selective OX1
antagonist –
under development...
- (ACT-539313)
Rocavorexant RTIOX-276 SB-334867 SB-408124
Suvorexant TCS-1102
Tebideutorexant (JNJ-61393215)
Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19...
- (ACT-539313)
Rocavorexant RTIOX-276 SB-334867 SB-408124
Suvorexant TCS-1102
Tebideutorexant (JNJ-61393215)
Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19...
-
receptor antagonist TCS-OX2-29 –
selective OX2
receptor antagonist Tebideutorexant (JNJ-61393215; JNJ-3215) –
selective OX1
receptor antagonist Spinazzi...
- (ACT-539313)
Rocavorexant RTIOX-276 SB-334867 SB-408124
Suvorexant TCS-1102
Tebideutorexant (JNJ-61393215)
Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19...
- (ACT-539313)
Rocavorexant RTIOX-276 SB-334867 SB-408124
Suvorexant TCS-1102
Tebideutorexant (JNJ-61393215)
Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19...
- (ACT-539313)
Rocavorexant RTIOX-276 SB-334867 SB-408124
Suvorexant TCS-1102
Tebideutorexant (JNJ-61393215)
Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19...
-
Darigabat (PF-06372865) –
GABAA receptor positive allosteric modulator Tebideutorexant (JNJ-61393215, JNJ-3215) –
orexin OX1
receptor antagonist 7-Oxoprasterone...
- (ACT-539313)
Rocavorexant RTIOX-276 SB-334867 SB-408124
Suvorexant TCS-1102
Tebideutorexant (JNJ-61393215)
Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19...
